DK143388D0 - Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-frigivelse hos pattedyr - Google Patents

Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-frigivelse hos pattedyr

Info

Publication number
DK143388D0
DK143388D0 DK143388A DK143388A DK143388D0 DK 143388 D0 DK143388 D0 DK 143388D0 DK 143388 A DK143388 A DK 143388A DK 143388 A DK143388 A DK 143388A DK 143388 D0 DK143388 D0 DK 143388D0
Authority
DK
Denmark
Prior art keywords
substituted
alkylidendithio
phenoles
mammals
bis
Prior art date
Application number
DK143388A
Other languages
English (en)
Other versions
DK175801B1 (da
DK143388A (da
Inventor
George Ku
Niall Doherty
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK143388D0 publication Critical patent/DK143388D0/da
Publication of DK143388A publication Critical patent/DK143388A/da
Application granted granted Critical
Publication of DK175801B1 publication Critical patent/DK175801B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK198801433A 1987-03-17 1988-03-16 Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af et lægemiddel til inhibering af interleukin-1-medierede virkninger bortset fra atherosklerose og/eller hyperlipidæmi DK175801B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2658687A 1987-03-17 1987-03-17
US2658687 1987-03-17
US15157288A 1988-02-18 1988-02-18
US15157288 1988-02-18

Publications (3)

Publication Number Publication Date
DK143388D0 true DK143388D0 (da) 1988-03-16
DK143388A DK143388A (da) 1988-09-18
DK175801B1 DK175801B1 (da) 2005-02-28

Family

ID=26701419

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198801433A DK175801B1 (da) 1987-03-17 1988-03-16 Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af et lægemiddel til inhibering af interleukin-1-medierede virkninger bortset fra atherosklerose og/eller hyperlipidæmi

Country Status (10)

Country Link
EP (1) EP0292660B1 (da)
JP (1) JP2671129B2 (da)
KR (1) KR960005704B1 (da)
AU (1) AU602961B2 (da)
DE (1) DE3869202D1 (da)
DK (1) DK175801B1 (da)
ES (1) ES2039489T3 (da)
GR (1) GR3004108T3 (da)
IE (1) IE60708B1 (da)
PH (1) PH23885A (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959392A (en) * 1989-07-24 1990-09-25 Merrell Dow Pharmaceuticals Inc. Method of treating diabetes mellitus
AU651873B2 (en) * 1991-03-18 1994-08-04 Merrell Dow Pharmaceuticals Inc. Method of inhibiting the progressive development of diabetes mellitus
FI951367A7 (fi) * 1994-03-28 1995-09-29 Japan Energy Corp Puriinijohdannaiset ja tulehdustautien tukahduttajat (suppressantit)
CN1275596C (zh) * 1997-05-14 2006-09-20 阿特罗吉尼克斯公司 普罗布考单酯在制备用于治疗心血管疾病和炎性疾病的药物中的应用
EP1695959A1 (en) * 1997-05-14 2006-08-30 Atherogenics, Inc. Compouds and methods for the inhibition of the expression of VCAM-1
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
AU2006202461B2 (en) * 1997-05-14 2009-12-03 Atherogenics, Inc. Compositions and methods for the inhibition of the expression of VCAM-1
WO1999001118A2 (en) 1997-07-01 1999-01-14 Atherogenics, Inc. Antioxidant enhancement of therapy for hyperproliferative conditions
US6881860B2 (en) 2000-04-11 2005-04-19 Atherogenics, Inc. Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality
EP2139320A4 (en) 2007-03-26 2010-09-08 Salutria Pharmaceuticals Llc METHODS AND COMPOSITIONS OF PROBUCOL DERIVATIVES FOR THE TREATMENT OF DIABETES
CN108299263B (zh) * 2018-01-30 2020-12-01 北京德默高科医药技术有限公司 一种普罗布考衍生物及其制备方法与应用

Also Published As

Publication number Publication date
EP0292660A2 (en) 1988-11-30
DK175801B1 (da) 2005-02-28
JP2671129B2 (ja) 1997-10-29
EP0292660B1 (en) 1992-03-18
IE60708B1 (en) 1994-08-10
EP0292660A3 (en) 1990-03-28
AU1316088A (en) 1988-09-15
PH23885A (en) 1989-12-18
ES2039489T3 (es) 1993-10-01
KR880010766A (ko) 1988-10-24
GR3004108T3 (da) 1993-03-31
KR960005704B1 (ko) 1996-05-01
AU602961B2 (en) 1990-11-01
JPS63258408A (ja) 1988-10-25
DK143388A (da) 1988-09-18
IE880786L (en) 1988-09-17
DE3869202D1 (de) 1992-04-23

Similar Documents

Publication Publication Date Title
DK460283A (da) Fremgangsmaade til fremstilling af topiske farmaceutiske praeparater
DK664387D0 (da) Fremgangsmaade til fremstilling af et anti-inflammatorisk farmaceutisk praeparat
DK143388D0 (da) Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-frigivelse hos pattedyr
ES550808A0 (es) Procedimiento de obtencion de preparados farmaceuticos de liberacion gradual prolongada
DK280282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider
DK51282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK226488D0 (da) Anvendelse af ace-inhibitorer til fremstilling af farmaceutiske praeparater
DK143688D0 (da) Anvendelse af disulfiram og to substituerede phenoler til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-frigivelse hos pattedyr
DK100289D0 (da) Fremgangsmaade til fremstilling af n-sulfonylurinstoffer
DK271588D0 (da) Genteknologisk fremgangsmaade til fremstilling af angiogeniner
DK635988D0 (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
NO172351C (no) Fremgangsmaate for fremstilling av glykopeptider
DK514785A (da) Fremgangsmaade til fremstilling af derivater af alkoholer
DK314988A (da) Fremgangsmaade til fremstilling af 6-deoxyguaninderivater
DK28788A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK574688D0 (da) Fremgangsmaade til fremstilling af propensyrederivater
DK601489A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK573888A (da) Fremgangsmaade til fremstilling af paramunitetsinducere
DK498388D0 (da) Fremgangsmaade til fremstilling af propensyrederivater
DK47681A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK475783D0 (da) Fremgangsmade til fremstilling af farmaceutiske praeparater
DK143889A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK184789A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK142788D0 (da) Fremgangsmaade til fremstilling af chlorerede olefiner
DK68790D0 (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler

Legal Events

Date Code Title Description
PUP Patent expired